Speed of cancer drug administration increasedNursing TimesPatients diagnosed with follicular non-Hodgkin lymphoma (NHL), previously had rituximab administered via an intravenous drip. But the trial at Southampton General Hospital can now deliver a two-…
Trust pioneers speedy injections of cancer treatmentHealth Service JournalPatients diagnosed with follicular non-Hodgkin lymphoma (NHL), previously had rituximab administered via an intravenous drip. But the trial at Southampton General Hospital can no…
 Medscape |
Radioimmunotherapy as Initial Therapy for Lymphoma
Medscape Although it was fairly easy to watch and wait when the only alternative was chemotherapy, it has become more difficult in the current era, when there are now 2 less toxic treatments that can be offered — upfront radioimmunotherapy and upfront rituximab. |
Vital cancer drug administered fastMSN NZ NewsPatients diagnosed with follicular non-Hodgkin lymphoma (NHL), a disease that attacks one specific type of infection-fighting cell, previously had rituximab administered via an intravenous drip. But the tri…
 Pharmazeutische Zeitung online |
Rituximab: Subkutan geht auch
Pharmazeutische Zeitung online Bei der Behandlung von Non-Hodgkin-Lymphomen ist die subkutane Applikation des monoklonalen Anti-CD20-Antikörpers Rituximab (Mabthera®) der intravenösen Gabe mindestens ebenbürtig. Darauf weist Hersteller Roche in einer Pressemitteilung hin. |
Oncology Robotics Live Patient Doses. Health Robotics: 343815 Doses …PR Newswire (press release)… Nelarabine, Nimustine, Ofatumumab, Oxaliplatin, Paclitaxel, Panitumumab, Pemetrexed, Raltitrexed, Rituximab, Streptozocin, Tabalumab, Thiotepa, Topote…
Medscape |
Liposomal Vincristine ‘Appears to Be a Step Forward’
Medscape … collaboration with the German High-Grade Non-Hodgkin’s Lymphoma Study Group and will directly compare the activity of VSLI and standard vincristine administered as part of the R-CHOP regimen (rituximab plus cyclophosphamide, hydroxydaunorubicin, … |
|
Optimizing the Quality and Accuracy of Biopharmaceutical Analysis and …
Genetic Engineering News (press release) He will present rituximab and bevacizumab glycan profile data generated with GlykoPrep-plus application on Agilent’s AssayMAP Bravo automated liquid handler. ProZyme and Agilent are collaborating to develop automated, high-precision workflows for … |
|
Age Matters When Treating Leukemia
dailyRx The authors conclude, “These data support the use of chlorambucil as an acceptable treatment for many older patients with CLL and suggest rituximab is beneficial regardless of age.” The authors also propose that these findings be considered when … |
|
New Tickborne Pathogen Found in US
MedPage Today This lack of reactivity may have resulted from the patient’s immunomodulating treatment with rituximab, according to Telford and colleagues. Misdiagnosis of meningoencephalitis with B. miyamotoi may be particularly likely in elderly patients, in whom … |